Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
about
Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosisPrimary prevention of variceal bleeding: pharmacological therapy versus endoscopic bandingRole of cardiovascular intervention as a bridge to liver transplantationBeta-blockers in liver cirrhosisRethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionRecent advances in the management of variceal bleedingA study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.Clinical pharmacology of portal hypertension.The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis.Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.Pulmonary arterial hypertension: an unusual cause of portal hypertension.After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension.Carvedilol in the treatment of portal hypertension.Endoscopic management of esophageal varices.Variceal rebleeding: use of drug therapy and endoscopic band ligation.Pathophysiology of portal hypertension and its clinical links.Is it time to replace propranolol with carvedilol for portal hypertension?Beta-blockers in patients with advanced liver disease: Has the dust settled?Prevention and management of variceal hemorrhage.Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.Prognosis of acute variceal bleeding: Is being on beta-blockers an aggravating factor? A short-term survival analysis.Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.Upper gastrointestinal haemorrhage: an update.Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis.Quantitative modeling of the physiology of ascites in portal hypertension.Carvedilol--NSBB of choice in all cirrhotics? Short title: Carvedilol for portal hypertension.Effects of contrast media on renal function in patients with cirrhosis: a prospective study.Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.Severe carvedilol toxicity without overdose - caution in cirrhosis.Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease.Prevention and management of gastroesophageal varices.Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding
P2860
Q24186341-353135EA-4CDF-458C-9F63-9E580AFC96F1Q26852622-41412800-5691-4AA6-9530-7C3A5F64C834Q27011341-08A29B15-C466-4F2B-A501-8B82196FB5D3Q27012922-CC32C58A-EB1D-452F-96CC-9342C1767FB9Q28069136-7FB9CE6E-54BE-4F2B-A195-2A79980A720FQ33647530-FC4C0483-CF79-4E57-9957-4C893041B0EFQ33721358-496FEC3B-64AD-4D4B-9396-E7E01C10A13CQ34399357-11F45C69-B7B9-411B-AB29-35968D9D60EEQ35707623-341440D2-0C3D-4A2C-AB43-A3F79AF6A063Q36008972-E06A0417-41BB-4411-A07D-E5460A166841Q36180004-33222DBD-AE90-460E-9363-AFD7E798591DQ36246310-251F5F99-334B-4CE4-9E0D-E97366B488C4Q36374829-58AAB074-B60F-4974-B89D-E4001D3E6AACQ37651909-25DDC3A4-3E26-4C13-B0D0-87C176689369Q37849484-5F566B94-2D77-4A22-A5D1-828F1FF96F6FQ38027840-F15B057B-32DF-486C-91D6-20BDCC7C2054Q38175517-839C6566-E7F5-417A-88AB-C7484341C1CCQ38371453-D69BF89E-01D2-452D-8E81-86459368F715Q38493078-BEF8B8BC-BFA9-47E2-A37E-BEB97D80EB26Q38673738-FDBA9893-F5B6-4A64-9617-6E8D8D257D21Q39842685-C02E8833-6ACD-4902-B975-1E1D4754EB44Q41036385-81B033CA-AD00-4CC9-9892-3DB590F80A1EQ41341900-6F225D1E-8BB1-4B60-875E-4DF5BB526427Q41411573-3226F962-EF5F-495E-B320-C0F4642A473AQ41582122-CCDB0248-87E6-44F5-80D1-D0C28D79626AQ41843561-DE683DC5-17A1-47A1-BC9D-8DF0BF66C5E5Q43112564-EF6B6CF6-0C35-495C-AFEE-BFD870D53293Q43183668-3E392D3F-DAD5-4CD5-9410-8B969F912272Q43189380-CA30DE70-4D53-4CD7-9382-C2BE035B6F16Q45045449-4DFEBD51-53DF-4987-A63C-D568E43F15C7Q45394131-A1C8E87C-171F-4A9C-94CC-B513E518DD15Q46636982-81FF2754-002E-48C3-ACA5-16F03393074DQ47100753-F3969961-2EC5-457C-9303-47140307D62BQ47263343-58F84EF0-1D3B-45B5-85AA-E7DD55FA8C1CQ49717262-A423ED99-C560-4260-A767-9A0A9C666921Q50442755-53ADB46D-DE5D-4EE7-A5AD-CCB501E2D017Q59133429-5A552A9F-20C6-47FA-A476-83AD61CB815F
P2860
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@en
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@nl
type
label
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@en
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@nl
prefLabel
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@en
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@nl
P2093
P356
P1433
P1476
Randomized comparison of long- ...... tal hypertension in cirrhosis.
@en
P2093
Agustín Albillos
Alejandro De Diego
Ana Matilla
Carlos Piera
Eduardo Moitinho
Jaime Bosch
José Luis Lampreave
Juan G Abraldes
P304
P356
10.1002/HEP.1840360612
P407
P577
2002-12-01T00:00:00Z